Hapuarachchi H A C, Dayanath M Y D, Abeysundara S, Bandara K B A T, Abeyewickreme W, de Silva N R
Department of Parasitology, Faculty of Medicine, University of Kelaniya, PO Box 6, Thalagolla Road, Ragama, Sri Lanka.
Ceylon Med J. 2004 Jun;49(2):47-51. doi: 10.4038/cmj.v49i2.3260.
To determine the occurrence and species distribution of malaria and the extent of chloroquine resistance among security forces personnel in a selected region of the Northern Province of Sri Lanka.
A descriptive study.
Mannar District in the Northern Province.
Nine hundred and seventy five security personnel were screened for malaria by microscopy. Those who were positive were treated with chloroquine and were subjected to 28 day in vivo assay to determine chloroquine resistance. In vitro microtest assay was performed to determine the response of Plasmodium falciparum isolates to chloroquine in vitro.
Of the 975 personnel screened, 181 (18.6%) were positive for malaria. P. falciparum was the predominant species (n = 125; 69.1%). The rest were due to P. vivax (n = 42; 23.2%) and mixed infections (n = 14; 7.7%). This was an inversion of the usual species distribution pattern in the country. In vivo assay revealed 38 (53.5%) P. falciparum infections as chloroquine resistant. Fifteen of 23 (65.2%) P. falciparum isolates showed evidence of resistance in vitro. None of the P. vivax infections showed evidence of chloroquine resistance. There was no significant difference in the severity of clinical disease between chloroquine resistant and sensitive infections at first presentation. Recrudescent P. falciparum infections had significantly lower mean parasite densities as well as lower clinical scores at recrudescence than at first presentation.
Results demonstrate the high prevalence of malaria and chloroquine resistance in the study area and explains several contributory factors for this. There is an urgent need to review antimalarial drug policies in Sri Lanka.
确定斯里兰卡北部省份某选定地区安全部队人员中疟疾的发生情况、种类分布以及氯喹耐药程度。
描述性研究。
北部省份的马纳尔区。
对975名安全人员进行显微镜检查以筛查疟疾。阳性者接受氯喹治疗,并进行28天的体内测定以确定氯喹耐药性。进行体外微量试验以测定恶性疟原虫分离株对氯喹的体外反应。
在975名接受筛查的人员中,181人(18.6%)疟疾检测呈阳性。恶性疟原虫是主要种类(n = 125;69.1%)。其余为间日疟原虫(n = 42;23.2%)和混合感染(n = 14;7.7%)。这与该国通常的种类分布模式相反。体内测定显示38例(53.5%)恶性疟原虫感染对氯喹耐药。23株恶性疟原虫分离株中有15株(65.2%)在体外显示出耐药证据。所有间日疟原虫感染均未显示氯喹耐药证据。初次就诊时,氯喹耐药和敏感感染的临床疾病严重程度无显著差异。复发性恶性疟原虫感染复发时的平均寄生虫密度和临床评分均显著低于初次就诊时。
结果表明研究地区疟疾和氯喹耐药的高流行率,并解释了造成这种情况的几个促成因素。斯里兰卡迫切需要审查抗疟药物政策。